Drugmakers Anticipate Positive Changes in a Potential Trump Administration
January 27, 2025 - 04:45
Pharmaceutical companies are expressing optimism about a possible second term for Donald Trump, anticipating a shift in focus towards addressing the role of pharmacy benefit managers (PBMs). Industry leaders believe that a renewed administration could prioritize initiatives aimed at increasing transparency and accountability among these intermediaries, which they argue can drive up drug costs for consumers.
In addition to tackling the influence of PBMs, drugmakers are hopeful for policies that emphasize innovation in drug development. They seek to foster an environment that encourages research and development, ultimately leading to the introduction of new therapies and treatments. This could enhance patient access to essential medications, a critical concern for many in the healthcare sector.
As the pharmaceutical industry navigates the complexities of the current healthcare landscape, the prospect of a Trump administration focusing on these key areas could significantly impact the future of drug pricing and availability for patients across the nation.
MORE NEWS
May 23, 2026 - 03:03
Guilford County Behavioral Health Center approaching 5 year anniversaryGuilford County`s Behavioral Health Center is nearing its five-year anniversary, and officials are highlighting its growing impact on the community. According to county data, the center served more...
May 22, 2026 - 01:51
Finding the sleep 'sweet spot' could help you live longer, study suggestsA study published in the journal Nature suggests that getting the right amount of sleep might be more important than previously thought for longevity. Researchers found that people who sleep too...
May 21, 2026 - 01:57
How to call for mental health help in ChicagoChicago residents have more options than ever for getting mental health support, but knowing which number to call can be confusing. Each service is designed for a different situation, and using the...
May 20, 2026 - 03:47
Affordable Care Act enrollment projected to plunge by 5 million as costs spike, analysis showsA new analysis projects that enrollment in the Affordable Care Act marketplace will fall by roughly 5 million people, a decline of more than 20%, as rising costs push coverage out of reach for many...